Efeito do salbutamol liberado através de inalador de pó seco sobre o broncoespasmo induzido por metacolina

Rubin, Adalberto Sperb; Pelegrin, Liliana G; Perin, Christiano; Leite, Maurício Roux; Silva, Luiz Carlos Corrêa da.
J. bras. pneumol ; 30(3): 195-200, maio-jun. 2004. tab, graf
Artículo en Portugués | LILACS | ID: lil-392957

Documentos relacionados

  1. Aerosolized drug delivery in awake and anesthetized children to treat bronchospasm.
  2. Effect of continuously nebulized ipratropium bromide plus albuterol on emergency department length of stay and hospital admission rates in patients with acute bronchospasm. A randomized, controlled trial.
  3. Response to albuterol MDI delivered through an anti-static chamber during nocturnal bronchospasm.
  4. Impact of different nebulisers' connections on aerosol therapy.
  5. An Innovative Method of Delivering Nebulized Medications for Perioperative Bronchospasm.
  6. Changes in heart rate associated with nebulized racemic albuterol and levalbuterol in intensive care patients.
  7. A randomized, controlled double-blind trial of usual-dose versus high-dose albuterol via continuous nebulization in patients with acute bronchospasm.
  8. Pharmacology Focus: Is it Time to Ditch the Albuterol Inhaler? S.M.A.R.T. Treatment for Asthma.
  9. Assessment and management of asthma exacerbations in an emergency department unit.
  10. Effect of different accessory devices on the dose delivered from pressurised metred-dose inhalers.